首页> 外文期刊>Genewatch : >Genetic Privacy in Europe
【24h】

Genetic Privacy in Europe

机译:欧洲的遗传隐私

获取原文
获取原文并翻译 | 示例
           

摘要

Genetic privacy in Europe is under threat as commercial companies seek to access electronic medical records held in national healthcare systems and to combine this data with individuals' whole genomes, all without their knowledge or consent. The aim is to make personalised risk assessments which can be used to market medicines and other products directly to consumers, vastly expanding the healthcare market. Policymakers are being lobbied to subsidize construction of these databases with taxpayers' money as a public-private partnership. Lobbyists aim to seek consent only after the databases have been built and the risk assessments have been calculated, at the point of feedback of these assessments to the individual. Because genomes act as biometrics - linking online data to an individual's physical person - other data will be connected to this system in the future, including government data (such as a person's use of social services and their education records) and online data such as search histories and social media. If these databases go ahead, it will also be possible to identify a persons genetic relatives and their heath and other data.
机译:随着商业公司试图访问国家医疗保健系统中保存的电子医疗记录并将这些数据与个人的整个基因组结合在一起,而没有他们的知情或同意,欧洲的遗传隐私受到了威胁。目的是进行个性化的风险评估,该评估可用于直接向消费​​者销售药品和其他产品,从而极大地扩展了医疗保健市场。决策者被游说用纳税人的钱作为公私合作伙伴关系来补贴这些数据库的建设。游说者的目标是仅在建立数据库并计算风险评估之后,才向这些个人反馈这些评估点。由于基因组充当生物识别技术-将在线数据链接到个人的自然人-将来其他数据将连接到该系统,包括政府数据(例如某人对社会服务的使用及其教育记录)和在线数据(例如搜索)历史和社交媒体。如果这些数据库继续进行,还将有可能确定一个人的遗传亲戚及其健康状况和其他数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号